JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, D. P.
Right arrow Articles by Park, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, D. P.
Right arrow Articles by Park, B. K.

Vol. 283, Issue 3, 1375-1382, 1997

Neutrophil Cytotoxicity of the Chemically Reactive Metabolite(s) of Clozapine: Possible Role in Agranulocytosis1

Dominic P. Williams, Munir Pirmohamed, Dean J. Naisbitt, James L. Maggs and B. Kevin Park

Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3BX, UK

Clozapine is associated with a 0.8% incidence of agranulocytosis. Bioactivation to an unstable protein-reactive metabolite, identified as a nitrenium intermediate, has been implicated in the toxicity. In this study, we investigated whether the reactive metabolite is cytotoxic toward polymorphonuclear leukocytes and mononuclear leukocytes using horseradish peroxidase and H2O2 to generate the metabolite in situ. In the absence of a full metabolizing system (i.e., lack of horseradish peroxidase and/or H2O2), clozapine (0-100 µM) and its stable metabolites were not cytotoxic. With a full metabolizing system, both clozapine (30 µM) and demethylclozapine exhibited cytotoxicity toward polymorphonuclear leukocytes (50.7 ± 7.7% and 17.6 ± 1.2% cell death, respectively) and mononuclear leukocytes (36.6 ± 2.1% and 24.6 ± 4.1%, respectively), whereas clozapine N-oxide was not cytotoxic. Exogenous glutathione (GSH), N-acetylcysteine and ascorbic acid all protected the cells. Bioactivation of clozapine and demethylclozapine, but not the N-oxide, was accompanied by depletion of intracellular GSH. [14C]Clozapine was metabolized to the previously identified C6 and C9 glutathionyl conjugates; GSH conjugates were also detected when demethylclozapine and clozapine N-oxide were bioactivated by horseradish peroxidase and H2O2. In conclusion, using a novel in vitro assay, we have shown that clozapine and its stable metabolites are not cytotoxic per se but are bioactivated to cytotoxic metabolites. The cytotoxic metabolite of clozapine is identical to the protein-reactive metabolite that has been characterized previously. These cytotoxic metabolites may play an important role in the pathogenesis of clozapine agranulocytosis; the mechanism by which this occurs is currently being investigated.

0022-3565/97/2833-1375$03.00/0
Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J Biomol ScreenHome page
L. Peternel, M. Kotnik, A. Prezelj, and U. Urleb
Comparison of 3 Cytotoxicity Screening Assays and Their Application to the Selection of Novel Antibacterial Hits
J Biomol Screen, February 1, 2009; 14(2): 142 - 150.
[Abstract] [PDF]

Home page
 Am J Health Syst PharmHome page
J. D. Evans and E. W. Evans
Review of eight restricted-access programs and potential implications for pharmacy
Am. J. Health Syst. Pharm., June 15, 2007; 64(12): 1302 - 1310.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. E. Mercer, J. L. Maggs, X.-M. Sun, G. M. Cohen, J. Chadwick, P. M. O'Neill, and B. K. Park
Evidence for the Involvement of Carbon-centered Radicals in the Induction of Apoptotic Cell Death by Artemisinin Compounds
J. Biol. Chem., March 30, 2007; 282(13): 9372 - 9382.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. P. Williams, M. Pirmohamed, D. J. Naisbitt, J. P. Uetrecht, and B. K. Park
Induction of Metabolism-Dependent and -Independent Neutrophil Apoptosis by Clozapine
Mol. Pharmacol., July 1, 2000; 58(1): 207 - 216.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
W. G. Lai, I. Gardner, N. Zahid, and J. P. Uetrecht
Bioactivation and Covalent Binding of Hydroxyfluperlapine in Human Neutrophils: Implications for Fluperlapine-Induced Agranulocytosis
Drug Metab. Dispos., March 1, 2000; 28(3): 255 - 263.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
I. Gardner, N. Zahid, D. MacCrimmon, and J. P. Uetrecht
A Comparison of the Oxidation of Clozapine and Olanzapine to Reactive Metabolites and the Toxicity of these Metabolites to Human Leukocytes
Mol. Pharmacol., June 1, 1998; 53(6): 991 - 998.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
I. Gardner, J. S. Leeder, T. Chin, N. Zahid, and J. P. Uetrecht
A Comparison of the Covalent Binding of Clozapine and Olanzapine to Human Neutrophils In Vitro and In Vivo
Mol. Pharmacol., June 1, 1998; 53(6): 999 - 1008.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.